Patent Assignment
Reel/Frame 018524/0632
Assignment of Assignor's Interest
Recorded: 2006-11-16
Pages: 4
Assignor
HOFFMANN-LA ROCHE INC.
Executed: 2006-11-03
Assignee
PDL BIOPHARMA, INC.
34801 CAMPUS DRIVE, FREMONT, CALIFORNIA, 94555
Covered Properties
(6)
Long Acting Formulation
Application:
06/823,896 →
Method of Preparing Long Acting Formulation
Patent:
4,940,556 →
Application:
07/057,469 →
Nicardipine Pharmaceutical Composition for Parenteral Administration
Application:
07/317,171 →
Long Acting Formulation
Application:
07/526,862 →
Nicardipine Pharmaceutical Composition for Parenteral Administration
Patent:
5,164,405 →
Application:
07/600,277 →
Long Acting Nicardipine Hydrochloride Formulation
Patent:
5,198,226 →
Application:
07/794,356 →
Related Assignments
(8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Jun 19, 1989
From: MAC FARLANE, CALUM B.; SELKIRK, ALISTAIR B.; DEY, MICHAEL J.
To: SYNTEX (U.S.A.) INC.
Reel/Frame 005156/0001 →
Assignment of Assignor's Interest
Jan 14, 2003
From: ROCHE HOLDINGS, INC.
To: HOFFMANN-LA ROCHE INC.
Reel/Frame 013653/0418 →
Assignment of Assignor's Interest
Jan 14, 2003
From: SYNTEX (U.S.A.) LLC (INTO WHICH SYNTEX (U.S.A.) INC. WAS MERGED)
To: ROCHE HOLDINGS, INC.
Reel/Frame 013653/0444 →
Assignment of Assignor's Interest
Apr 5, 2007
From: MACFARLANE, CALUM B.; SELKIRK, ALISTAIR B.; DEY, MICHAEL J.
To: SYNTEX (U.S.A.) INC.
Reel/Frame 019116/0504 →
Merger
Apr 5, 2007
From: SYNTEX (U.S.A.) INC.
To: SYNTEX (U.S.A.) LLC
Reel/Frame 019116/0508 →
Assignment of Assignor's Interest
Jul 18, 2008
From: PDL BIOPHARMA, INC.
To: EKR THERAPEUTICS, INC.
Reel/Frame 021253/0306 →
To Correct an Error in a Cover Sheet Previously Re
Nov 17, 2008
From: PDL BIOPHARMA, INC.
To: EKR THERAPEUTICS, INC.
Reel/Frame 021842/0719 →
Security Agreement
Dec 15, 2008
From: EKR THERAPEUTICS, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 021976/0780 →